Advertisement

neurogenetics

, Volume 10, Issue 3, pp 241–250 | Cite as

Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes

  • S. Russo
  • M. Marchi
  • F. Cogliati
  • M. T. Bonati
  • M. Pintaudi
  • E. Veneselli
  • V. Saletti
  • M. Balestrini
  • B. Ben-Zeev
  • L. Larizza
Original Article

Abstract

It has been found that CDKL5 gene mutations are responsible for early-onset epilepsy and drug resistance. We screened a population of 92 patients with classic/atypical Rett syndrome, 17 Angelman/Angelman-like patients and six idiopathic autistic patients for CDKL5 mutations and exon deletions and identified seven novel mutations: six in the Rett subset and one in an Angelman patient. This last, an insertion in exon 11, c.903_904 dupGA, p.Leu302Aspfx49X, is associated with a relatively mild clinical presentation as the patient is the only one capable of sitting and walking alone. Of the six mutations, two are de novo missense changes affecting highly conserved aminoacid residues, c.215 T > C p.Ile72Thr and c.380A > G p.His127Arg (present in a mosaic condition) found in two girls with the most severe clinical presentation, while the remaining are the splicing c.145 + 2 T > C and c.2376 + 5G > A, the c.1648C > T p.Arg550X and the MPLA-identified c.162_99del261 mutation. RNA characterisation of four mutations revealed the aberrant transcript of the missense allele (case 2) and not the stop mutation (case 3), but also allowed the splicing mutation (case 1) and the c.-162_99del261 (case 4) to be categorised as truncating. The obtained data reinforce the view that a more severe phenotype is due more to an altered protein than haploinsufficiency. Furthermore, the mutational repertoire of the CDKL5 gene is shown to be expanded by testing patients with phenotypical overlap to Rett syndrome and applying multiplex ligation-dependent probe amplification.

Keywords

Mutation screening RNA analysis Genotype–phenotype correlation 

Notes

Acknowledgements

We thank A.I.R. (Associazione Italiana Rett) for support of this study by a dedicated grant and for making available their daughters' samples and Galliera Genetic Bank for establishment of lymphoblastoid cell lines. This study was supported by the European grant E-Rare JTC 2007 (to S.R.) entitled European Network on Rett Syndrome.

Supplementary material

10048_2009_177_MOESM1_ESM.xls (17 kb)
Supplementary Table 2 (XLS 17 KB)
10048_2009_177_Fig1_ESM.gif (220 kb)
Supplementary Fig. 6

Electropherogram of the splicing mutation affecting IVS16 carried by patient 7 and spliceview analysis, which predicts splicing consensus abolition (GIF 219 KB)

10048_2009_177_Fig1_ESM.tif (131 kb)
High resolution (TIFF 131 KB)

References

  1. 1.
    Kalscheuer VM, Tao J, Donnelly A, Hollway G, Schwinger E, Kubart S, Menzel C, Hoeltzenbein M, Tommerup N, Eyre H, Harbord M, Haan E, Sutherland GR, Ropers HH, Gecz J (2003) Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation. Am J Hum Genet 72:1401–1411. doi: 10.1086/375538 PubMedCrossRefGoogle Scholar
  2. 2.
    Grosso S, Brogna A, Bazzotti S, Renieri A, Morgese G, Balestri P (2007) Seizures and electroencephalographic findings in CDKL5 mutations: case report and review. Brain Dev 29(4):239–242. doi: 10.1016/j.braindev.2006.09.001 PubMedCrossRefGoogle Scholar
  3. 3.
    Nectoux J, Heron D, Tallot M, Chelly J, Bienvenu T (2006) Maternal origin of a novel C-terminal truncation mutation in CDKL5 causing a severe atypical form of Rett syndrome. Clin Genet 70:29–33. doi: 10.1111/j.1399-0004.2006.00629.x PubMedCrossRefGoogle Scholar
  4. 4.
    Li M, Pan H, Bao XH, Zhang YZ, Wu XR (2007) MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome. J Hum Genet 52:38–47. doi: 10.1007/s10038-006-0079-0 PubMedCrossRefGoogle Scholar
  5. 5.
    Rosas-Vargas H, Bahi-Buisson N, Philippe C, Nectoux J, Girard B, N'Guyen MA, Gitiaux C, Lazzaro L, Odent S, Jonveaux P, Chelly J, Bienvenu T (2008) Impairment of CDKL5 nuclear localization as a cause for severe infantile encephalopathy. J Med Genet 45:172–178. doi: 10.1136/jmg.2007.053504 PubMedCrossRefGoogle Scholar
  6. 6.
    Bahi-Buisson N, Nectoux J, Rosas-Vargas H, Milh M, Boddaert N, Girard B, Cances C, Ville D, Afenjar A, Rio M, Héron D, N'Guyen Morel MA, Arzimanoglou A, Philippe C, Jonveaux P, Chelly J, Bienvenu T (2008) Key clinical features to identify girls with CDKL5 mutations. Brain 131:2647–2661. doi: 10.1093/brain/awn197 PubMedCrossRefGoogle Scholar
  7. 7.
    Bahi-Buisson N, Kaminska A, Boddaert N, Rio M, Afenjar A, Gérard M, Giuliano F, Motte J, Héron D, Morel MA, Plouin P, Richelme C, des Portes V, Dulac O, Philippe C, Chiron C, Nabbout R, Bienvenu T (2008) The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia 49(6):1027–1037. doi: 10.1111/j.1528-1167.2007.01520.x PubMedCrossRefGoogle Scholar
  8. 8.
    Montini E, Andolfi G, Caruso A, Buchner G, Walpole SM, Mariani M, Consalez G, Trump D, Ballabio A, Franco B (1998) Identification and characterization of a novel serine threonine kinase gene from the Xp22 region. Genomics 51:427–433. doi: 10.1006/geno.1998.5391 PubMedCrossRefGoogle Scholar
  9. 9.
    Lin C, Franco B, Rosner MR (2005) CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders. Hum Mol Genet 24:3775–3786. doi: 10.1093/hmg/ddi391 CrossRefGoogle Scholar
  10. 10.
    Rusconi L, Salvatoni L, Giudici L, Bertani I, Kilstrup-Nielsen C, Broccoli V, Landsberger N (2008) CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail. J Biol Chem 283(44):30101–30111 doi: 10.1074/jbc.M804613200 Google Scholar
  11. 11.
    Mari F, Azimonti S, Bertani I, Bolognese F, Colombo E, Caselli R, Scala E, Longo I, Grosso S, Pescucci C, Ariani F, Hayek G, Balestri P, Bergo A, Badaracco G, Zappella M, Broccoli V, Renieri A, Kilstrup-Nielsen C, Landsberger N (2005) CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 14:1935–1946. doi: 10.1093/hmg/ddi198 PubMedCrossRefGoogle Scholar
  12. 12.
    Bertani I, Rusconi L, Bolognese F, Forlani G, Conca B, De Monte L, Badaracco G, Landsberger N, Kilstrup-Nielsen C (2006) Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation. J Biol Chem 281(42):32048–32056. doi: 10.1074/jbc.M606325200 PubMedCrossRefGoogle Scholar
  13. 13.
    Weaving CJ, Ellaway J Gécz, Christodoulou J (2005) Rett syndrome: clinical review and genetic update. J Med Genet 42:1–7. doi: 10.1136/jmg.2004.027730 PubMedCrossRefGoogle Scholar
  14. 14.
    Pintaudi M, Baglietto MG, Gaggero R, Parodi E, Pessagno A, Marchi M, Russo S, Veneselli E (2008) Clinical and electroencephalographic features in patients with CDKL5 mutations: two new Italian cases and review of literature. Epilepsy Behav 12:326–331. doi: 10.1016/j.yebeh.2007.10.010 PubMedCrossRefGoogle Scholar
  15. 15.
    Elia M, Falco M, Ferri R, Spalletta A, Bottitta M, Calabrese G, Carotenuto M, Musumeci SA, Lo Giudice M, Fichera M (2008) CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy. Neurol (Tokyo) 71:997–999Google Scholar
  16. 16.
    Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, Magenis RE, Moncla A, Schinzel AA, Summers JA, Wagstaff J (2006) Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A 140:413–418. doi: 10.1002/ajmg.a.31074 PubMedGoogle Scholar
  17. 17.
    Mnatzakanian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, MacLeod PJM, Jones JR, Scherer SW, Schanen NC, Friez MJ, Vincent JB, Minassian BA (2004) A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 36(4):339–341. doi: 10.1038/ng1327 PubMedCrossRefGoogle Scholar
  18. 18.
    Muralidhar B, Butler MG (1998) Methylation PCR analysis of Prader-Willi syndrome, Angelman syndrome, and control subjects. Am J Med Genet 16(80):263–265. doi: 10.1002/(SICI) 1096-8628(19981116) 80:3<263::AID-AJMG16>3.0.CO;2-G CrossRefGoogle Scholar
  19. 19.
    Scala E, Ariani F, Mari F, Caselli R, Pescucci C, Longo I, Meloni I, Giachino D, Bruttini M, Hayek G, Zappella M, Renieri A (2005) CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms. J Med Genet 42:103–107. doi: 10.1136/jmg.2004.026237 PubMedCrossRefGoogle Scholar
  20. 20.
    Allen RC, Zoghby HY, Mosely AB, Rosenblatt HM, Belmon JW (1992) Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229–1239PubMedGoogle Scholar
  21. 21.
    Evans JC, Hayley L, Colley JP, Ravn K, Nielsen JB, Kerr A, Williams E, Christodoulou J, Gecz J, Jardine PE, Wright MJ, Pilz DT, Lazarou L, Cooper DN, Sampson JR, Butler R, Whatley SD, Clarke AJ (2005) Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet 13:1113–1120. doi: 10.1038/sj.ejhg.5201451 PubMedCrossRefGoogle Scholar
  22. 22.
    Tao J, Esch VH, Hagedorn-Greiwe M, Hoffman K, Moser B, Raynaud M, Sperner J, Fryns JP, Schwinger E, Gezc J, Ropers HH, Kalsheuer VM (2004) Mutations in the X-linked Cyclin-dependent Kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet 75:1149–1154. doi: 10.1086/426460 PubMedCrossRefGoogle Scholar
  23. 23.
    Nishimura A, Takano T, Mizuguchi T, Saitsu H, Takeuchi Y, Matsumoto N (2008) CDKL5 distruption by t(X;18) in a girl with West syndrome. Clin Genet 74(3):288–290PubMedCrossRefGoogle Scholar
  24. 24.
    Watson P, Black G, Ramsden S, Barrow M, Super M, Kerr B, Clayton-Smith J (2001) Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet 38:224–228. doi: 10.1136/jmg.38.4.224 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • S. Russo
    • 1
  • M. Marchi
    • 1
  • F. Cogliati
    • 1
  • M. T. Bonati
    • 1
  • M. Pintaudi
    • 2
  • E. Veneselli
    • 2
  • V. Saletti
    • 3
  • M. Balestrini
    • 3
  • B. Ben-Zeev
    • 4
  • L. Larizza
    • 1
    • 5
  1. 1.Molecular Genetics LaboratoryIstituto Auxologico ItalianoMilanItaly
  2. 2.Department of Child Neuropsychiatry, G. Gaslini HospitalUniversity of GenoaGenoaItaly
  3. 3.Unit of Developmental NeurologyIstituto Neurologico Carlo BestaMilanItaly
  4. 4.Sheba Med. CtrRamat-GanIsrael
  5. 5.Division of Medical Genetics, San Paolo School of MedicineUniversity of MilanMilanItaly

Personalised recommendations